Abiopharma

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

FDA approve TOLVAPTAN

FDA approve TRIFAROTENE

New Form SC14D9C - Adverum Biotechnologies, Inc. Filed: 2025-10-24 AccNo: 0001193125-25-249440 Size: 243 KB

(90% Positive) Adverum Biotechnologies, Inc. (ADVM) Announces Business Combination

Farag Kameel D. 🟢 acquired 6.3K shares of Akari Therapeutics Plc (AKTX) at $0.74 Transaction Date: Oct 22, 2025 | Filing ID: 019194

New Form 6-K - GSK plc Filed: 2025-10-24 AccNo: 0001654954-25-012176 Size: 69 KB

New Form 3 - Akari Therapeutics Plc Filed: 2025-10-24 AccNo: 0001493152-25-019192 Size: 12 KB

Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

New Form 10-K/A - Premier, Inc. Filed: 2025-10-24 AccNo: 0001577916-25-000015 Size: 2 MB

(85% Positive) Pulse Biosciences, Inc. (PLSE) Announces Enrollment Update for Surgeon Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine

General Announcement: IPT - Use of Market Capitalisation as Basis for Computing Materiality Thresholds

New Form D - Akari Therapeutics Plc Filed: 2025-10-24 AccNo: 0001493152-25-019187 Size: 14 KB